Potential of Circulating Pro-angiogenic MicroRNA Expressions As Biomarkers for Rapid Angiographic Stenotic Progression and Restenosis Risks in Coronary Artery Disease Patients Underwent Percutaneous Coronary Intervention

Overview

Journal J Clin Lab Anal

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
Pathology

Date 2019 Sep 10

PMID 31495986

Citations 12

Authors

Rui Dai

Yijue Liu

Yi Zhou

Xiaoju Xiong

Wei Zhou

Weijuan Li

Wenping Zhou

Manhua Chen

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to investigate the correlation of pro-angiogenic microRNA (miRNA) expressions with rapid angiographic stenotic progression (RASP) and restenosis risks in coronary artery disease (CAD) patients underwent percutaneous coronary intervention (PCI) with drug-eluting stents (DES).

Methods: A total of 286 CAD patients underwent PCI with DES were consecutively recruited in this study. Plasma samples were collected before PCI operation, and 14 pro-angiogenic miRNAs were measured by real-time quantitative reverse transcription-polymerase chain reaction. Rapid angiographic stenotic progression at nontarget lesions and restenosis at stented lesions were evaluated by quantitative coronary angiography at 12 months after PCI operation.

Results: The occurrence rates of RASP and restenosis were 39.5% and 22.4%, respectively. Let-7f, miR-19a, miR-19b-1, miR-92a, miR-126, miR-210, and miR-296 were decreased in RASP patients than non-RASP patients, among which let-7f, miR-19a, miR-126, miR-210, and miR-296 independently correlated with lower RASP occurrence by multivariate analysis, followed by receiver-operating characteristic (ROC) curve exhibited that these five miRNAs showed great value in predicting RASP risk with area under curve (AUC) 0.879 (95% CI: 0.841-0.917). Besides, let-7f, miR-19a, miR-92a, miR-126, miR-130a, and miR-210 were reduced in restenosis patients than non-restenosis patients, among them miR-19a, miR-126, miR-210, and miR-378 independently correlated with lower restenosis occurrence by multivariate analysis, followed by ROC curve disclosed that these four miRNAs had good value in predicting restenosis risk with AUC 0.776 (95% CI: 0.722-0.831).

Conclusions: Circulating let-7f, miR-19a, miR-126, miR-210, and miR-296 independently correlate with reduced RASP risk, while miR-19a, miR-126, miR-210, and miR-378 independently correlate with decreased restenosis risk in CAD patients underwent PCI with DES.

Citing Articles

The role of MicroRNAs in mesenchymal stem cell differentiation into vascular smooth muscle cells.

Abolhasani S, Ahmadi Y, Rostami Y, Fattahi D Cell Div. 2025; 20(1):6.

PMID: 40055797 PMC: 11887104. DOI: 10.1186/s13008-025-00146-0.

New Biomarkers for Cardiovascular Disease.

Kim S, Mesquita F, Hochman-Mendez C Tex Heart Inst J. 2023; 50(5).

PMID: 37846107 PMC: 10658139. DOI: 10.14503/THIJ-23-8178.

MicroRNA‑378: An important player in cardiovascular diseases (Review).

Wang H, Shi J, Wang J, Hu Y Mol Med Rep. 2023; 28(3).

PMID: 37503766 PMC: 10436248. DOI: 10.3892/mmr.2023.13059.

High miR-126-3p levels associated with cardiovascular events in a general population.

Martinez-Arroyo O, Ortega A, Flores-Chova A, Sanchez-Garcia B, Garcia-Garcia A, Chaves F Eur J Intern Med. 2023; 113:49-56.

PMID: 37080818 PMC: 10271715. DOI: 10.1016/j.ejim.2023.04.013.

The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization.

Spadaccio C, Nenna A, Rose D, Piccirillo F, Nusca A, Grigioni F J Cardiovasc Transl Res. 2022; 15(5):1024-1048.

PMID: 35357670 DOI: 10.1007/s12265-022-10241-0.

References

Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J . MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med. 2014; 20(4):368-76. PMC: 4398028. DOI: 10.1038/nm.3487. View

Stanik-Hutt J . Drug-coated stents: preventing restenosis in coronary artery disease. J Cardiovasc Nurs. 2004; 19(6):404-8. DOI: 10.1097/00005082-200411000-00012. View

Levine G, Bates E, Blankenship J, Bailey S, Bittl J, Cercek B . 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and.... J Am Coll Cardiol. 2011; 58(24):e44-122. DOI: 10.1016/j.jacc.2011.08.007. View

Jansen F, Stumpf T, Proebsting S, Franklin B, Wenzel D, Pfeifer P . Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6. J Mol Cell Cardiol. 2017; 104:43-52. DOI: 10.1016/j.yjmcc.2016.12.005. View

Zhang H, Hao J, Sun X, Zhang Y, Wei Q . Circulating pro-angiogenic micro-ribonucleic acid in patients with coronary heart disease. Interact Cardiovasc Thorac Surg. 2018; 27(3):336-342. DOI: 10.1093/icvts/ivy058. View

Lee C, Kim S, Suh J, Park D, Lee S, Kim Y . Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Catheter Cardiovasc Interv. 2008; 71(5):594-8. DOI: 10.1002/ccd.21399. View

Guenther S, Schrepfer S . miR-126: a potential new key player in hypoxia and reperfusion?. Ann Transl Med. 2016; 4(19):377. PMC: 5075839. DOI: 10.21037/atm.2016.08.22. View

Yu S, Hong Q, Wang Y, Hou K, Wang L, Zhang Y . High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a. Circ J. 2015; 79(11):2487-98. DOI: 10.1253/circj.CJ-15-0283. View

Nakamura K, Keating J, Edelman E . Pathology of Endovascular Stents. Interv Cardiol Clin. 2017; 5(3):391-403. PMC: 6588793. DOI: 10.1016/j.iccl.2016.02.006. View

10.

Daniel J, Penzkofer D, Teske R, Dutzmann J, Koch A, Bielenberg W . Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury. Cardiovasc Res. 2014; 103(4):564-72. PMC: 4145012. DOI: 10.1093/cvr/cvu162. View

11.

Uchida T, Popma J, Stone G, Ellis S, Turco M, Ormiston J . The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions. JACC Cardiovasc Interv. 2010; 3(4):403-11. DOI: 10.1016/j.jcin.2010.01.010. View

12.

Schulte C, Molz S, Appelbaum S, Karakas M, Ojeda F, Lau D . miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease. PLoS One. 2016; 10(12):e0145930. PMC: 4699820. DOI: 10.1371/journal.pone.0145930. View

13.

Nikolic I, Plate K, Schmidt M . EGFL7 meets miRNA-126: an angiogenesis alliance. J Angiogenes Res. 2010; 2(1):9. PMC: 2901201. DOI: 10.1186/2040-2384-2-9. View

14.

Khattab A, Otto A, Hochadel M, Toelg R, Geist V, Richardt G . Drug-eluting stents versus bare metal stents following rotational atherectomy for heavily calcified coronary lesions: late angiographic and clinical follow-up results. J Interv Cardiol. 2007; 20(2):100-6. DOI: 10.1111/j.1540-8183.2007.00243.x. View

15.

Jin Y, Pang T, Nelin L, Wang W, Wang Y, Yan J . MKP-1 is a target of miR-210 and mediate the negative regulation of miR-210 inhibitor on hypoxic hPASMC proliferation. Cell Biol Int. 2014; 39(1):113-20. DOI: 10.1002/cbin.10339. View

16.

Lou Y, Guo F, Liu F, Gao F, Zhang P, Niu X . miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol Cell Biochem. 2012; 370(1-2):45-51. DOI: 10.1007/s11010-012-1396-6. View

17.

van Solingen C, Bijkerk R, de Boer H, Rabelink T, van Zonneveld A . The Role of microRNA-126 in Vascular Homeostasis. Curr Vasc Pharmacol. 2013; 13(3):341-51. DOI: 10.2174/15701611113119990017. View

18.

Lun W, Wu X, Deng Q, Zhi F . MiR-218 regulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via targeting CTGF. Cancer Cell Int. 2018; 18:83. PMC: 5994014. DOI: 10.1186/s12935-018-0575-2. View

19.

Hata J, Kiyohara Y . Epidemiology of stroke and coronary artery disease in Asia. Circ J. 2013; 77(8):1923-32. DOI: 10.1253/circj.cj-13-0786. View

20.

Jin F, Xing J . Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity. Neurol Sci. 2017; 38(11):2015-2023. DOI: 10.1007/s10072-017-3071-x. View